LENZ Therapeutics is a pharmaceutical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead product is VIZZ, an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors. Learn more about VIZZ eye drops at www.VIZZ.com
Company Details
- Employees
- 144
- Address
- 125 S Highway 101, San Diego,california 92075,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://LENZ-Tx.com
- Keywords
- jobs.
- HQ
- San Diego, California
Lenz Therapeutics Questions
Lenz Therapeutics's website is https://LENZ-Tx.com
Lenz Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lenztx
Lenz Therapeutics has
144 employees.
View email and phone details for 144
employees at Lenz Therapeutics.
Lenz Therapeutics's industry is
Pharmaceutical Manufacturing
Lenz Therapeutics's top competitors are
Orasis Pharmaceuticals,
Glaukos Corporation,
Rxsight, Inc.,
Alcon,
Tarsus Pharmaceuticals, Inc.,
Eyenovia, Inc.,
Ocular Therapeutix, Inc.,
Abbvie,
Bausch + Lomb,
Apellis Pharmaceuticals.
Lenz Therapeutics's categories are Pharmaceutical Manufacturing
